Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
April 20, 2021

Second indication of Sarclisa for relapsed multiple myeloma approved by EC

The second indication of Sarclisa (isatuximab) for the treatment of adult patients with relapsed multiple myeloma, was approved by the European Commission (EC).

Continue
This second approval of Sarclisa is in combination with carfilzomib and dexamethasone (Kd) for adult patients who have received at least one prior therapy. Credit: Anton/Unsplash.
March 10, 2021

Japan’s Takeda to acquire the US’ Maverick Therapeutics

Japan-based Takeda Pharmaceutical Company Limited has entered into an agreement to acquire private biopharmaceutical company Maverick Therapeutics, Inc. in a bid to expand its novel immuno-oncology portfolio. Credit: National Cancer Institute/Unsplash
February 9, 2021

USFDA awards Breakthrough Therapy designation to Novartis’ asciminib

Medicines that are being assessed for critical conditions are granted BTD if early clinical evidence indicates significant improvement potential over available therapy. Credit: Vachagan Malkhasyan from Pixabay

Contracts

March 17, 2021

AstraZeneca to deliver 500,000 more doses of AZD7442 to US

AstraZeneca’s long-acting antibody (LAAB) combination AZD7442 is in the late-stage development for the prevention and treatment of the Covid-19 virus. Credit: Steven Cornfield/Unsplash.

Enveric Biosciences signs licensing agreement with Diverse Biotech

Ocugen signs agreement with Bharat Biotech to distribute Covid-19 vaccine in the US

Lilly to provide antibody therapies at Indiana hospitals for treating COVID-19

Deals

Deals April 19, 2021

US clearance granted for AstraZeneca’s proposed acquisition of Alexion

Pharmaceutical Business Review

Dr. Reddy’s secures EUA for Sputnik V in India

Sanofi acquires Tidal Therapeutics

Piramal to acquire APIs manufacturer Hemmo Pharmaceuticals

Popular

  1. GSK and Vir announce EMA review of VIR-7831 for early treatment of Covid-19
  2. European Commission grants Bristol Myers Squibb approval for Opdivo to treat RCC
  3. SciNeuro and Eli Lilly sign exclusive license agreement for alpha-synuclein in Greater China
  4. Trodelvy granted accelerated approval by USFDA for metastatic urothelial cancer
  5. Airway Therapeutics’ IND application for AT-100 gets FDA acceptance to treat Covid-19

PRESS RELEASES

Pharmaceutical Business Review
Tosoh Bioscience Introduces TSKgel® FcR-IIIA-5PW HPLC Column
CBDepot and 4MP Cannabidiol Novel Food Applications with the UK Food Standards Agency Declared Validated and Verified Food Supplements
CBDepot and 4MP Cannabidiol Novel Food Applications with the UK Food Standards Agency Declared Validated and Verified Food Supplements
Novo Nordisk Pharmatech’s New CEO Has a Head Start
Novo Nordisk Pharmatech’s New CEO Has a Head Start
Gerresheimer Participates in the European Joint Project Furnace for the Future (F4F)
Gerresheimer Participates in the European Joint Project Furnace for the Future (F4F)
Strategikon Pharma Announces New Software Release of Clinical Maestro
Strategikon Pharma Announces New Software Release of Clinical Maestro

Suppliers

Whitepapers

SnAP Reagents
SnAP Reagents
Diazirines for Photoaffinity Labelling
Diazirines for Photoaffinity Labelling
Sulfoximines for Drug Design
Sulfoximines for Drug Design